Maturity Onset Diabetes of the Young Overview

Save information for later
Sign Up

Learn About Maturity Onset Diabetes of the Young

What is the definition of Maturity Onset Diabetes of the Young?
Maturity-onset diabetes of the young (MODY) is a form of diabetes that is characterized by an early onset diabetes. MODY represents about 2% of all diabetes cases and is commonly misdiagnosed as type 1 or type 2 diabetes mellitus. It is due to a primary defect in pancreatic beta cell function. It is inherited in an autosomal dominant pattern.
What are the alternative names for Maturity Onset Diabetes of the Young?
  • Maturity-onset diabetes of the young
  • MODY
  • Mason type diabetes
Who are the top Maturity Onset Diabetes of the Young Local Doctors?
Elite in Maturity Onset Diabetes of the Young
Kevin C. Colclough
Elite in Maturity Onset Diabetes of the Young
Kevin C. Colclough
Exeter, ENG, GB 

Kevin Colclough practices in Exeter, United Kingdom. Mr. Colclough is rated as an Elite expert by MediFind in the treatment of Maturity Onset Diabetes of the Young. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), and Type A Insulin Resistance Syndrome.

Elite in Maturity Onset Diabetes of the Young
Magdalena Szopa
Elite in Maturity Onset Diabetes of the Young
Magdalena Szopa
Jakubowskiego 2 St, 
Krakow, MA, PL 

Magdalena Szopa practices in Krakow, Poland. Ms. Szopa is rated as an Elite expert by MediFind in the treatment of Maturity Onset Diabetes of the Young. Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Macrosomia, Gastrectomy, and Gastric Bypass.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Maturity Onset Diabetes of the Young
Dr. Louis H. Philipson
Endocrinology
Elite in Maturity Onset Diabetes of the Young
Dr. Louis H. Philipson
Endocrinology

The University Of Chicago

5841 S Maryland Ave, 
Chicago, IL 
773-702-1000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Louis Philipson is an Endocrinologist in Chicago, Illinois. Dr. Philipson is rated as an Elite provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Islet Cell Transplantation, and Pancreatectomy.

View All Doctors
What are the latest Maturity Onset Diabetes of the Young Clinical Trials?
Investigating Enteroendocrine Dysfunction, Metabolism, and Response to Liraglutide in Patients With Maturity-onset Diabetes of the Young (MODY)
Investigating Enteroendocrine Dysfunction, Metabolism, and Response to Liraglutide in Patients With Maturity-onset Diabetes of the Young (MODY)
Enrollment Status: Recruiting
Publish Date: June 19, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: The reason for this research study is to better understand the use of liraglutide, a commonly prescribed Type 2 diabetes medication, in patients with a diagnosis of maturity-onset diabetes of the young (MODY). The investigators are interested in better understanding the way that this drug affects the metabolism and hormone levels of a person with MODY. Many people with MODY report having gastroint...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Optimized Diagnosis and Precision Medicine of MODY (Maturity-Onset Diabetes of the Young)
Optimized Diagnosis and Precision Medicine of MODY (Maturity-Onset Diabetes of the Young)
Enrollment Status: Recruiting
Publish Date: November 01, 2023

Summary: The goal of this observation is to establish a complete registry for the clinical manifestations, environment, genetic, and other related gene variation information of young-onset diabetic patients. Moreover, according to the physiological and pathological mechanisms of different genes, the impact on the clinical characteristics of diabetes, the therapeutic response to drugs, and the impact on com...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center